Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10-chloro-11b-(2'-fluorophenyl)-2,3,5,6,7,11b-hexahydro-7-(2''-hydroxyethyl)benzo(6,7)-1,4-diazepino(5,4-b)oxazol-6-one
2. Ms 4101
1. 27060-91-9
2. Coreminal
3. 5g2k7o5d8s
4. 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-3,5-dihydro-2h-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
5. 10-chloro-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)oxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one
6. Flutazolamum
7. Flutazolam [inn:jan]
8. Flutazolamum [inn-latin]
9. Ms-4101
10. Brn 1092501
11. Unii-5g2k7o5d8s
12. Coreminal (tn)
13. 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo(3,2-d) [1,4]benzodiazepin-6(7h)-one
14. 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo(3,2-d)[1,4]benzodiazepin-6(7h)-one
15. 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-6(7h)-one
16. 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(7h)-one
17. Flutazolam [mi]
18. Flutazolam (jan/inn)
19. Flutazolam [inn]
20. Flutazolam [jan]
21. Flutazolam [mart.]
22. Flutazolam [who-dd]
23. 10-chloro-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)oxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one
24. Schembl546958
25. Chembl1697836
26. Dtxsid6023072
27. Chebi:31628
28. Oxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one, 10-chloro-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)-
29. Hy-111481
30. Cs-0042166
31. D01286
32. Q5462935
33. 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,5,11b-tetrahydrooxazolo(3,2-d)[ 1,4]benzodiazepin-6(7h)-one
34. 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5h)-one
| Molecular Weight | 376.8 g/mol |
|---|---|
| Molecular Formula | C19H18ClFN2O3 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 376.0989983 g/mol |
| Monoisotopic Mass | 376.0989983 g/mol |
| Topological Polar Surface Area | 53 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 539 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Flutazolam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flutazolam, including repackagers and relabelers. The FDA regulates Flutazolam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flutazolam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Flutazolam supplier is an individual or a company that provides Flutazolam active pharmaceutical ingredient (API) or Flutazolam finished formulations upon request. The Flutazolam suppliers may include Flutazolam API manufacturers, exporters, distributors and traders.
click here to find a list of Flutazolam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Flutazolam Drug Master File in Japan (Flutazolam JDMF) empowers Flutazolam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Flutazolam JDMF during the approval evaluation for pharmaceutical products. At the time of Flutazolam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Flutazolam suppliers with JDMF on PharmaCompass.
Flutazolam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flutazolam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flutazolam GMP manufacturer or Flutazolam GMP API supplier for your needs.
A Flutazolam CoA (Certificate of Analysis) is a formal document that attests to Flutazolam's compliance with Flutazolam specifications and serves as a tool for batch-level quality control.
Flutazolam CoA mostly includes findings from lab analyses of a specific batch. For each Flutazolam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flutazolam may be tested according to a variety of international standards, such as European Pharmacopoeia (Flutazolam EP), Flutazolam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flutazolam USP).
LOOKING FOR A SUPPLIER?
